138 related articles for article (PubMed ID: 17974988)
1. Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy.
Svensson RU; Barnes JM; Rokhlin OW; Cohen MB; Henry MD
Cancer Res; 2007 Nov; 67(21):10445-54. PubMed ID: 17974988
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
Kim KI; Kang JH; Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2007 Sep; 48(9):1553-61. PubMed ID: 17704247
[TBL] [Abstract][Full Text] [Related]
3. Regulation of CMV promoter-driven exogenous gene expression with doxorubicin in genetically modified cells.
Kinoshita A; Kobayashi D; Hibino Y; Isago T; Uchino K; Yagi K; Hirai M; Saitoh Y; Komada F
J Pharm Pharmacol; 2008 Dec; 60(12):1659-65. PubMed ID: 19000371
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
5. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
6. The effect of high intensity focused ultrasound on luciferase activity on two tumor cell lines in vitro, under the control of a CMV promoter.
Hundt W; Steinbach S; O'Connell-Rodwell CE; Bednarski MD; Guccione S
Ultrasonics; 2009 Mar; 49(3):312-8. PubMed ID: 19019402
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
8. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
[TBL] [Abstract][Full Text] [Related]
9. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
10. Effects of anticancer agents and scavengers on CMV-promoter-driven exogenous gene expression in genetically modified cells.
Kinoshita A; Kobayashi D; Saitoh Y; Komada F
J Pharm Pharmacol; 2009 Apr; 61(4):527-31. PubMed ID: 19298701
[TBL] [Abstract][Full Text] [Related]
11. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Kachi S; Esumi N; Zack DJ; Campochiaro PA
Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
[TBL] [Abstract][Full Text] [Related]
12. Optimization of tetracycline-responsive recombinant protein production and effect on cell growth and ER stress in mammalian cells.
Jones J; Nivitchanyong T; Giblin C; Ciccarone V; Judd D; Gorfien S; Krag SS; Betenbaugh MJ
Biotechnol Bioeng; 2005 Sep; 91(6):722-32. PubMed ID: 15981277
[TBL] [Abstract][Full Text] [Related]
13. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.
Lin YD; Chen S; Yue P; Zou W; Benbrook DM; Liu S; Le TC; Berlin KD; Khuri FR; Sun SY
Cancer Res; 2008 Jul; 68(13):5335-44. PubMed ID: 18593935
[TBL] [Abstract][Full Text] [Related]
14. An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine.
Lai MD; Chen CS; Yang CR; Yuan SY; Tsai JJ; Tu CF; Wang CC; Yen MC; Lin CC
Cancer Gene Ther; 2010 Mar; 17(3):203-11. PubMed ID: 19851354
[TBL] [Abstract][Full Text] [Related]
15. Bioluminescence imaging after HSV amplicon vector delivery into brain.
Pike L; Petravicz J; Wang S
J Gene Med; 2006 Jul; 8(7):804-13. PubMed ID: 16602134
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive imaging of firefly luciferase reporter gene expression using bioluminescence imaging in human prostate cancer models.
Li H; Li JZ; Helm GA; Pan D
Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):179-84. PubMed ID: 17073822
[TBL] [Abstract][Full Text] [Related]
17. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
[TBL] [Abstract][Full Text] [Related]
18. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.
Joo SS; Yoo YM
J Pineal Res; 2009 Aug; 47(1):8-14. PubMed ID: 19522739
[TBL] [Abstract][Full Text] [Related]
19. High levels of protein expression using different mammalian CMV promoters in several cell lines.
Xia W; Bringmann P; McClary J; Jones PP; Manzana W; Zhu Y; Wang S; Liu Y; Harvey S; Madlansacay MR; McLean K; Rosser MP; MacRobbie J; Olsen CL; Cobb RR
Protein Expr Purif; 2006 Jan; 45(1):115-24. PubMed ID: 16289982
[TBL] [Abstract][Full Text] [Related]
20. Androgen-dependent activation of human cytomegalovirus major immediate-early promoter in prostate cancer cells.
Moon JS; Lee MY; Park SW; Han WK; Hong SW; Ahn JH; Kim KS
Prostate; 2008 Sep; 68(13):1450-60. PubMed ID: 18615458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
